Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 20.
Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Real-time in situ FTIR analysis has become a standard tool in the chemical and pharmaceutical industries for providing information rich data that allows a more thorough understanding of reactions during the development and scale-up of chemical processes. METTLER TOLEDO is offering a free webinar discussing the Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool on November 11, 2009. (PRWeb Nov 4, 2009)
Read the full story at http://www.prweb.com/releases/chemical/processes/prweb3149614.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Drug Side Effects & Clinical Trials Website Receives HONCode CertificationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drug Side Effects & Clinical Trials, an up-and-coming provider of targeted drug side effects information announces its receipt of HONCode Certification. This is a landmark award for the promising 7-month old niche medical website. (PRWeb Nov 4, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3152984.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Avoco Secure Releases The First Information Card (I-Card) Cloud Selector, the First I-Card Cloud Signer and also a Unique Anti-Phishing AuthenticationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Avoco Secure today announced it has launched the first Information Card Cloud Selector and I-Card Cloud signer, which both have a zero desktop install, so they work with any browser installed on any device, anywhere. They offer customers enhanced security including anti-phishing, as well as a user friendly experience and the ability to easily sign web content like mortgage application forms. (PRWeb Nov 3, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3140224.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Pharmaceuticals Giant Selects MBO Partners and Atrium Staffing for Independent Contractor Engagement and ComplianceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MBO Partners has been selected to provide enterprise-wide contingent workforce risk mitigation and compliance solutions to one of the largest pharmaceuticals companies in the world. The program, in partnership with diversity supplier Atrium Staffing, will allow the client to safely and cost-effectively engage highly valuable independent contractors (http://www.mbopartners.com/businesses/riskmitigation.html) and SOW consultants. (PRWeb Nov 3, 2009)
Read the full story at http://www.prweb.com/releases/independent/contractors/prweb3150884.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Formatta Presents Forms-Driven Business Process Optimization Webinar for Healthcare on Thursday, November 19 at 1 p.m. EasternEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Formatta Forms Optimization Solution Enables Organizations To Drive Down Costs While Providing Better Patient Care (PRWeb Nov 3, 2009)
Read the full story at http://www.prweb.com/releases/Forms_Optimization/e-Forms/prweb3151994.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A bold new approach using adult stem cell therapy has created an international medical first and raised the hope of patients with pulmonary fibrosis, a life threatening disease with as yet no known cure. (PRWeb Nov 3, 2009)
Read the full story at http://www.prweb.com/releases/adistem/stem-cell-therapy/prweb3146654.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
SIUE School of Pharmacy, SLU Pharmacology Receive $975K NIH GrantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Southern Illinois University Edwardsville School of Pharmacy (http://www.siue.edu/pharmacy/) has been awarded -- along with the Saint Louis University Department of Pharmacology and Physiology -- a $974,024 National Institutes of Health (NIH) grant to study ways of relieving chronic pain through new approaches in treating neuroinflammation. (PRWeb Nov 3, 2009)
Read the full story at http://www.prweb.com/releases/SIUE/NIH_grant/prweb3137374.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Omnicare Pays Nearly $100 Million to Resolve Medicaid Fraud Charges: Second Omnicare Settlement With Chicago Whistleblower PharmacistEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Omnicare, Inc., which calls itself "the nation's leading provider of pharmaceutical care for seniors," paid $98 million to settle Medicaid fraud charges involving various kickback schemes. Among other claims, the government alleged that Omnicare had committed Medicaid fraud by taking payments from pharmaceutical manufacturer Johnson & Johnson to induce pharmacies to switch patients to Risperdal® from other anti-psychotic medications. Omnicare's Risperdal® had originally been reported by a Chicago pharmacist whistleblower, who was fired by Omnicare after reporting the switching. This is the...
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Latest Version of Fullscope Data Collection Now AvailableEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New release includes additional industry-specific data collection functionality for process manufacturers. The robust web-based tool helps increase warehouse and operational efficiencies by improving real-time inventory control and reducing the risk of data entry errors. (PRWeb Nov 3, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3152564.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Ivax Pharmaceuticals to Pay $14 Million to Resolve False Claims Act Lawsuit; Omnicare to Pay $98 Million to Resolve False Claims Act AllegationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ivax Pharmaceuticals and Omnicare have entered into settlement agreements with the United States to resolve False Claims Act allegations. Shelley R. Slade, attorney for qui tam plaintiff David Kammerer, comments on the policy concerns and implications of the settlements. (PRWeb Nov 3, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3156114.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
American Society Of Interventional Pain Physicians (ASIPP) Launches Resident & Fellows SectionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In an effort to foster the education and development of aspiring pain physicians by means of establishing evidence-based guidelines of clinical practice and responsible patient care, the American Society of Interventional Pain Physicians (ASIPP) has introduced a Resident and Fellow's section. (PRWeb Nov 2, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3151344.htm
Source: PRWeb: Medical Pharmaceuticals - November 4, 2009 Category: Pharmaceuticals Source Type: news
Ortho Clinical Diagnostics Launches First-of-its-kind Remote Monitoring Center(Nov 4, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Paris, France (November 4th, 2009) Ortho Clinical Diagnostics (OCD) today announced the launch of a first-of-its-kind 24-7 central command center in Strasbourg, France, that continuously tracks the condition of clinical laboratory instrument performance. The Remote Monitoring Center in Strasbourg provides unique predictive monitoring services to laboratories throughout Europe and the Asia-Pacific region by continuously detecting and tracking potential instrument problems up to 30 days in advance, before they interrupt the ability of the lab to deliver quality test results.....
Source: Johnson and Johnson - November 4, 2009 Category: Pharmaceuticals Source Type: organizations
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company advances 3rd internally discovered program into clinical studies
CAMBRIDGE, Mass.--(HSMN NewsFeed)--Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blo... Biopharmaceuticals, OncologyAcceleron Pharma, ACE-041, angiogenesis, TGF-β, TGF-beta
Source: HSMN NewsFeed - November 4, 2009 Category: Pharmaceuticals Source Type: news
AtriCure Announces Tentative Settlement with the Department of JusticeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WEST CHESTER, Ohio--(HSMN NewsFeed)--AtriCure, Inc. (Nasdaq: ATRC ), a medical device company and a leader in cardiac surgical ablation systems, today announced that it has reached a tentative agreement, subject to completion and approval of a written sett... Devices, Cardiology, LitigationAtriCure, cardiac ablation, atrial fibrillation
Source: HSMN NewsFeed - November 4, 2009 Category: Pharmaceuticals Source Type: news
Lesser-Known Effects of Smoking Can Play Havoc with Women's Health(Nov 4, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Toronto, Canada (November 4th, 2009)- Many women are aware that smoking can lead to lung cancer, heart disease and premature death. But a recent survey conducted by Angus Reid on behalf of nicotine replacement therapy brands, NICODERM(R) and NICORETTE(R) reveals that the majority of Canadian women who smoke are not necessarily aware of the host of other impacts that smoking can have on their immediate and longer term health.....
Source: Johnson and Johnson - November 4, 2009 Category: Pharmaceuticals Source Type: organizations
Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care DressingsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RICHMOND, Va., Nov. 4 (HSMN NewsFeed) -- Filtrona Porous Technologies, manufacturer of custom fluid handling fiber and foam components for the medical device and healthcare industry, and a division of UK-based Filtrona plc (Pink Sheets: FLRAF ), has rece... Devices, Wound CareFiltrona Porous Technologies, MediSponge RBR, MediSponge
Source: HSMN NewsFeed - November 4, 2009 Category: Pharmaceuticals Source Type: news
Nation?s Largest Nursing Home Pharmacy and Drug Manufacturer to Pay $112 Million to Settle False Claims Act CasesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
U.S. Also Files Complaint Against Two Atlanta-Based Nursing Home
Chainsand Their Principals
WASHINGTON, Nov. 3, 2009 — The nation’s largest
nursing home pharmacy, Omnicare Inc. of Covington, Kentucky, will
pay $98 million, and drug...
Source: Drugs.com - Pharma News - November 4, 2009 Category: Pharmaceuticals Source Type: news
Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and BlepharitisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DURHAM, N.C.--(HSMN NewsFeed)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH ) announced today patient enrollment is complete in three of its late-stage clinical trials.
We are pleased to be executing on our strategic plan with the achievement of these p... Biopharmaceuticals, OphthalmologyInspire Pharmaceuticals, PROLACRIA, AZASITE, azithromycin, Denufosol
Source: HSMN NewsFeed - November 4, 2009 Category: Pharmaceuticals Source Type: news
Entra Health Systems and the Telemedicine Reference Center Launch the First Mobile Phone-Based Telehealth Solution Using MyGlucoHealth Wireless Diabetic Monitoring TechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO and DHAKA, Bangladesh, Nov. 4, 2009 (GLOBE NEWSWIRE) -- Entra Health Systems, an international applied healthcare technology company, and the Telemedicine Reference Center Ltd. (TRCL) of Dhaka, a pioneer in eHealth, today launched AmCare -- Intensive Diabetes Management, the world's first integrated mobile phone-based telehealth network that uses MyGlucoHealth Wireless diabetic monitoring technology. In Bangladesh, TRCL will operate eHealth call centers to provide diabetes patient care using Entra Health's new MyGlucoHealth Wireless Bluetooth(R)-enabled blood glucose meter.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PASADENA, Calif.--(HSMN NewsFeed)--Arrowhead Research Corporation (NASDAQ:ARWR ) today announced that its majority owned subsidiary, Calando Pharmaceuticals, Inc., has appointed Mostafa Analoui, Ph.D., and Bruce D. Given, MD, to its Board of Directors.
... Biopharmaceuticals, PersonnelCalando Pharmaceuticals, Cyclosert, RONDEL, nanoparticle
Source: HSMN NewsFeed - November 4, 2009 Category: Pharmaceuticals Source Type: news
EDAP Announces Webcast and Conference Call of Third Quarter 2009 ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LYON, France, Nov. 4, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2009 earnings announcement, which will take place on Tuesday, November 17, 2009, before the opening of the market.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
Long-term Outcomes Data Validates the Utility of PROSTASCINT in Guiding Targeted Prostate Cancer Treatment and Predicting Disease Free SurvivalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LANGHORNE, Pa., Nov. 4 /PRNewswire/ -- EUSA Pharma announced
that PROSTASCINT® (capromab pendetide) fusion imaging was shown
to effectively guide prostate cancer therapy targeting and dosing
and is a significant predictor of disease free...
Source: Drugs.com - Clinical Trials - November 4, 2009 Category: Pharmaceuticals Source Type: clinical trials
Ingen Receives $100K Purchase Order Today for New Oxyview Nasal CannulaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
YUCAIPA, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the company has received a purchase order from MedOx Corporation for 40,000 new Oxyview Nasal Cannulas in value of $100,000.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
Pain Therapeutics to Present at the Credit Suisse Healthcare ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN MATEO, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the Credit Suisse Healthcare Conference on Wednesday, November 11th at 2:30 p.m. Mountain Standard Time.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
New Phase IIa data on TMC435 in patients with hepatitis C presented at the ongoing AASLD - meetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
STOCKHOLM, Nov. 4, 2009--Data were presented from the phase IIa
trial (OPERA-1) for TMC435 at the ongoing 60th annual meeting of
the American Association for the Study of Liver Diseases in Boston,
USA.
TMC435 is an investigational protease...
Source: Drugs.com - Clinical Trials - November 4, 2009 Category: Pharmaceuticals Source Type: clinical trials
New Merck Begins OperationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
With Robust Pipeline, Broader Product Portfolio and Expanded
Global Presence
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Nov 4, 2009 - Merck
& Co., Inc. (NYSE: MRK) today outlined its global plans
following the completion of Merck's merger with...
Source: Drugs.com - Pharma News - November 4, 2009 Category: Pharmaceuticals Source Type: news
New Merck Begins Operations WorldwideEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Operates in More Than 140 Countries Including Canada
WHITEHOUSE STATION, NJ, Nov. 4 /CNW Telbec/ - Merck & Co.,
Inc. (NYSE: MRK) today outlined its global strategy following the
completion yesterday of Merck's merger with...
Source: Drugs.com - Pharma News - November 4, 2009 Category: Pharmaceuticals Source Type: news
Rockwell Medical Reports Third Quarter Results; Expanded Gross Profit MarginsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WIXOM, Mich., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, reported today third quarter 2009 sales of $14.2 million, up 4.6% from $13.5 million in the third quarter of 2008. Loss for the third quarter 2009 was ($1.5) million or ($.11) per share compared to ($2.5) million or ($.18) per share for the third quarter of 2008.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
Emergent Group Inc. Reports Record Third Quarter Revenue and Net IncomeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SUN VALLEY, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Emergent Group Inc. (NYSE Amex Equities:LZR), a leading provider of mobile medical lasers and surgical equipment, today announced record third quarter 2009 sales and net income as the company continued to move forward with its growth strategies despite the current general economic climate.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
Symyx Direct 6.3 Adds Markush Structure Storage and RetrievalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SUNNYVALE, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Symyx Technologies, Inc. (Nasdaq:SMMX) has released the Symyx Direct 6.3 chemistry data cartridge, which now includes new capabilities in the handling of non-specific Markush chemical structures. Symyx Direct enables researchers to register, search and retrieve molecular structures and reactions stored in Oracle(R) relational databases. Used by more than 80 percent of life sciences organizations worldwide, the cartridge offers proven performance with databases containing over 17 million reactions and over 30 million structures.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, Nov. 4 (HSMN NewsFeed) -- NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix® Phase III clinical trial... Biopharmaceuticals, Oncology, FDANovaRx, Lucanix, NSCLC
Source: HSMN NewsFeed - November 4, 2009 Category: Pharmaceuticals Source Type: news
Integra LifeSciences Reports Third Quarter 2009 Financial ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PLAINSBORO, N.J., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2009. Total revenues were $172.3 million, reflecting an increase of $5.3 million, or 3%, over the third quarter of 2008. Excluding the impact of currency exchange rates, revenues increased 4%. Revenues by product category are presented in a table at the end of this press release.
Source: Medical News (via PRIMEZONE) - November 4, 2009 Category: Pharmaceuticals Source Type: news
CONCERTA® in the Classroom: New Data on Attention in Children With ADH(Nov 4, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
>Las Vegas, NV (November 4th, 2009) -- New findings presented today show that CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) is the only stimulant medication with data that demonstrate a significant treatment effect on attention at one hour and through 12.5 hours in children with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a common and treatable medical condition characterized by inattention, hyperactivity and impulsivity(1) that is estimated to affect about 5 million children(2) in the United States.....
Source: Johnson and Johnson - November 4, 2009 Category: Pharmaceuticals Source Type: organizations
Water Wise: Abbott Saving 1 Billion Gallons AnnuallyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott is saving 1 billion gallons of water annually since launching a comprehensive, global effort in 2004.
Source: PharmaManufacturing.com - November 4, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
Man Sentenced For Sale And Supply Of Controlled And Counterfeit DrugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Medicines and Healthcare products Regulatory Agency (MHRA) discovered more than 86,000 Valium tablets and a further 11,500 medicinal products in an undercover investigation into Gami's illegal online dealing.
Source: Pharmaceutical Online News - November 4, 2009 Category: Pharmaceuticals Source Type: news
FDA Unveils Safe Use Initiative That Targets Preventable Harm From Medication UseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.S. Food and Drug Administration recently announced the Safe Use Initiative, a program aimed at reducing the likelihood of preventable harm from medication use.
Source: Pharmaceutical Online News - November 4, 2009 Category: Pharmaceuticals Source Type: news
New Mocon-Certified Testing Lab To Open In MumbaiEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MOCON, Inc. is partnering with Hemetek Techno Instruments, Mumbai, India to establish a certified testing lab there. The lab officially opens January 2010.
Source: Pharmaceutical Online News - November 4, 2009 Category: Pharmaceuticals Source Type: news
New Merck Begins OperationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merck & Co., Inc. today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday. The new Merck is a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value.
Source: Pharmaceutical Online News - November 4, 2009 Category: Pharmaceuticals Source Type: news
Novartis To Expand Its Human Vaccines Presence In China Through Proposed Acquisition Of A Majority Stake In Zhejiang TianyuanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novartis has reached an agreement to acquire an 85% stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. as part of a strategic initiative to build a vaccines industry leader in this country and expand the Group's limited presence in this fast-growing market segment.
Source: Pharmaceutical Online News - November 4, 2009 Category: Pharmaceuticals Source Type: news
Plan Creates Long-Term Care BenefitEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
One provision of the health-care legislation would create a new federal long-term care benefit that would pay cash to people who become disabled.
Source: WSJ.com: Health - November 4, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Early Health-Care Vote Isn't LikelyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Time is running short for Congress to deliver a health bill to Obama before the year's end, prompting lawmakers to prepare for the debate to carry into 2010.
Source: WSJ.com: Health - November 4, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Novartis to Invest in ChinaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novartis's CEO said the company will spend $1 billion to make China a third global pillar for its research and development.
Source: WSJ.com: Health - November 4, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Plan Creates Long-Term Care BenefitEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
One provision of the health-care legislation would create a new federal long-term care benefit that would pay cash to people who become disabled.
Source: WSJ.com: Health - November 4, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Early Health-Care Vote Isn't LikelyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Time is running short for Congress to deliver a health bill to Obama before the year's end, prompting lawmakers to prepare for the debate to carry into 2010.
Source: WSJ.com: Health - November 4, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Swine-Flu Deaths Higher in the ElderlyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
People age 50 and older who were hospitalized with the swine flu in California had the highest fatality rate from the illness, while the those younger than 18 had the lowest death rates.
Source: WSJ.com: Health - November 4, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Access Feature Story: Helping to Protect the Sight of Future GenerationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Merck.com - Feature Stories About Merck - November 4, 2009 Category: Pharmaceuticals Source Type: organizations
Access Feature Story: Providing Free Vaccinations to Nicaraguan BabiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Merck.com - Feature Stories About Merck - November 4, 2009 Category: Pharmaceuticals Source Type: organizations
Environment Feature Story: A Shining Example of Environmental CommitmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Merck.com - Feature Stories About Merck - November 4, 2009 Category: Pharmaceuticals Source Type: organizations
Community Feature Story: Helping to Close the Gaps in Diabetes CareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Merck.com - Feature Stories About Merck - November 4, 2009 Category: Pharmaceuticals Source Type: organizations
